How many PRP injections do you actually need?

HOW MANY

There is no magic in a series of three. The number is a clinical decision made from your tissue and your response, and anyone quoting you a course before they have examined you is selling a package rather than planning treatment.

Where the number three came from

Largely from convention and from how clinics schedule, not from a trial that tested three against two. It became the default answer because it is a tidy thing to say and an easy thing to book.

What the evidence does support is narrower and more useful: in knee osteoarthritis, comparative work has found multiple injections outperforming a single one, and a separate line of research finds that the total platelet dose delivered correlates with outcome. Those are two different claims. The first is about repetition; the second is about how much you actually got. A clinic using a low-yield preparation may need three to reach what another delivers in one.

Which is why the question “how many” cannot be answered without knowing what is in the syringe. Two syringes labeled PRP can behave in opposite directions, and that is most of why the trials disagree.

What actually decides it

• The tissue. A tendon and a joint do not behave the same way. Tendon remodeling runs over months and is more likely to justify a second treatment; an intra-articular knee injection is judged differently. Each tissue has its own clock.
• What the first one did. This is the honest driver. A meaningful partial response at six to eight weeks is the best argument for a second. No response at all is an argument for re-examining the diagnosis, not for repeating the injection.
• The stage of the joint. The knee is where this treatment has the most to stand on, and the earlier grades respond better than the late ones.
• Your terrain. The biology doing the repair is yours. Why a pain clinic asks to see your bloodwork is not a digression here — it is the variable most likely to be limiting the result.

Our position, stated plainly

We do not pre-book a course. Intervals are scheduling facts; quantities are clinical decisions, and the decision is made after we see what the tissue did. If you are told at the first visit that you need exactly three, ask what would change that number. A good answer exists. If none is offered, the number was not clinical.

The corollary is the part people like less: sometimes the honest answer after one injection is that this is not the right treatment for your problem, and a second will not fix that. Being told you are not a candidate is the point of asking.

What the consensus documents say

Expert consensus and guideline groups have converged on PRP being a reasonable option in knee osteoarthritis while being explicit that preparation and protocol heterogeneity limits how precisely anyone can specify a regimen. That is an honest position and it is the one we hold: the evidence supports the treatment more confidently than it specifies the schedule.

It is worth separating two things that get conflated. PRP is not covered by most payers — that is a budgeting decision. It is a different statement from anything about the strength of the evidence, and not covered is not the same as unproven.